Article Details
Retrieved on: 2020-12-10 16:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
As biosimilars eat away market share, <b>Roche</b> is offering discounts to its top-selling cancer drugs Herceptin, Rituxan and Avastin. (<b>Roche</b>).
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here